Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Kalbe Farma Tbk PT ADR

PTKFY
Current price
22.59 USD 0 USD (0.00%)
Last closed 22.59 USD
ISIN US69368A1088
Sector Healthcare
Industry Drug Manufacturers - General
Exchange PINK
Capitalization 6 398 753 280 USD
Yield for 12 month -22.37 %
1Y
3Y
5Y
10Y
15Y
PTKFY
21.11.2021 - 28.11.2021

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. PT Kalbe Farma Tbk. was incorporated in 1966 and is headquartered in Jakarta, Indonesia. Address: Gedung KALBE, Jakarta, Indonesia, 10510

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

P/E ratio

26.5765

Dividend Yield

2.05 %

Current Year

+1 978 402 535 USD

Last Year

+126 953 USD

Current Quarter

+32 273 USD

Last Quarter

+34 933 USD

Current Year

+768 203 749 USD

Last Year

+49 655 USD

Current Quarter

+12 281 USD

Last Quarter

+13 444 USD

Key Figures PTKFY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 4 662 542 467 072 USD
Operating Margin TTM 13.55 %
PE Ratio 26.5765
Return On Assets TTM 8.88 %
PEG Ratio
Return On Equity TTM 13.65 %
Wall Street Target Price
Revenue TTM 31 598 456 078 336 USD
Book Value 471.5 USD
Revenue Per Share TTM
Dividend Share 31 USD
Quarterly Revenue Growth YOY 9 %
Dividend Yield 2.05 %
Gross Profit TTM 11 518 600 753 369 USD
Earnings per share 0.85 USD
Diluted Eps TTM 0.85 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 26 %
Profit Margin 9.63 %

Dividend Analytics PTKFY

Dividend growth over 5 years

41 %

Continuous growth

3 years

Payout Ratio 5 years average

7234 %

Dividend History PTKFY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 0.38
Ex Dividend Date 31.05.2024
Forward Annual Dividend Yield 2.05 %
Last Split Factor 5:1
Payout Ratio 46.15 %
Last Split Date 25.10.2012
Dividend Date 01.07.2024

Stock Valuation PTKFY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 26.5765
Forward PE 18.8324
Enterprise Value Revenue 2.4568
Price Sales TTM 0.0002
Enterprise Value EBITDA 17.4692
Price Book MRQ 3.0221

Financials PTKFY

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators PTKFY

For 52 weeks

16.68 USD 22.59 USD
50 Day MA 21.08 USD
Shares Short Prior Month
200 Day MA 21.18 USD
Short Ratio
Shares Short
Short Percent